1. Challenging Statin Intolerance: Back to Basics

2. NLA on Statin Intolerance

3. Ask Yourself: What Is the Cause?

4. Spectrum of Statin-Associated Muscle Adverse Events

5. Incidence/Prevalence of Statin Intolerance

6. Rethinking Statins

7. Not All Statins Are Created Equal

8. Statins: High/Medium/Low

9. CYP450

10. Statin Pharmacokinetics

11. Pitavastatin and Pravastatin: Minimal CYP Involvement

12. Drugs That Interfere With Statin Medications

13. Human Cytochrome P450 Isoenzymes Known to Oxidize Clinically Used Drugs

14. Metabolizing Enzymes and Transporters Involved in Statin Drug-Drug Interactions

15. Gemfibrozil With Statin Drug-Drug Interactions

16. NLA Recommendations What Should Providers Do?

17. Let the Patient Tell You About Their Symptoms

18. NLA Recommendations: Consistent With Those Found in the ACC's Tool

19. Myth Busters

20. 2015 ACC Health Policy Statement Team Management

21. Abbreviations